Yamashita Health Care Holdings,Inc.

TSE:9265.T

2561 (JPY) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q2
Revenue 16,18216,47414,87814,02116,47014,06414,19013,47114,509.66113,300.32414,450.17412,885.67120,347.63917,280.92616,973.60615,528.90716,712.10514,854.18717,111.75415,980.46317,159.03214,986.26315,111.09214,276.86717,140.57713,92414,07213,55615,41312,76512,47111,86814,82912,26313,05311,47015,22111,85212,65510,58214,62312,79912,08011,54713,72411,27611,353
Cost of Revenue 13,77614,33212,79812,16114,13012,09712,29511,62512,271.64111,481.77312,496.00211,171.98618,040.95415,425.43915,170.33613,983.76614,838.5713,338.37915,239.87114,436.32215,199.62513,475.95713,505.02212,847.20415,155.27712,43812,55512,23213,73111,41211,07310,56813,04510,87411,62010,16113,39010,50011,2039,38312,85611,26510,55310,17012,0629,9749,996
Gross Profit 2,4062,1422,0801,8602,3401,9671,8951,8462,238.021,818.5511,954.1721,713.6852,306.6851,855.4871,803.271,545.1411,873.5351,515.8081,871.8831,544.1411,959.4071,510.3061,606.071,429.6631,985.31,4861,5171,3241,6821,3531,3981,3001,7841,3891,4331,3091,8311,3521,4521,1991,7671,5341,5271,3771,6621,3021,357
Gross Profit Ratio 0.1490.130.140.1330.1420.140.1340.1370.1540.1370.1350.1330.1130.1070.1060.10.1120.1020.1090.0970.1140.1010.1060.10.1160.1070.1080.0980.1090.1060.1120.110.120.1130.110.1140.120.1140.1150.1130.1210.120.1260.1190.1210.1150.12
Reseach & Development Expenses 00000000000000000000000000000000000000000000000
General & Administrative Expenses 1,9250001,5630001,6440001,717.3310001,304000-3,537.6730001,0730001,0780001,0940001,1760001,2470001,15200
Selling & Marketing Expenses 34400032900031000029400028500027100029200026300024800022000019100017000
SG&A 2,2691,9301,6531,6601,8921,6671,5531,5831,9541,6291,4931,5112,011.3311,6061,4411,4791,5891,5941,4401,442-3,537.6731,4581,4141,4591,3651,4951,4251,4521,3411,3621,3551,3361,3421,3251,2351,3141,3961,3031,2291,2451,4381,3361,2201,2261,3221,2701,169
Other Expenses 01112141116131018.95215.0519.95113.70611.00112.913.83314.82916.67113.93417.4716.4519.11618.92418.15313.89216.1880000000000000000000000
Operating Expenses 2,2691,9301,6581,6632,0731,6701,5571,5862,160.221,629.1161,492.8581,511.4722,014.8261,605.9941,441.7871,479.1281,768.431,593.8991,440.1661,442.341,651.4431,457.9271,414.2381,459.5161,566.561,5481,3991,4391,4681,4921,3361,3311,4471,3241,2241,2971,4771,2921,2221,2201,5661,4021,2071,2121,4591,2611,143
Operating Income 13721242219626129733925977.793189.435461.315202.211291.854249.493361.48366.012105.101-78.092431.716101.801307.95852.38191.831-29.853418.731-992-128188-943-3632864198-531349223-4618119830715119832188
Operating Income Ratio 0.0080.0130.0280.0140.0160.0210.0240.0190.0050.0140.0320.0160.0140.0140.0210.0040.006-0.0050.0250.0060.0180.0030.013-0.0020.024-0.0010.007-0.0090.012-0.0010.003-0.0030.0220.0050.015-00.0210.0040.018-0.0040.0120.0150.0250.0130.0140.0030.017
Total Other Income Expenses Net 13-19110724116-600222621262312.7537.03615.74317.173-20.07744.31324.50933.051-188.02931.64821.683-5.619-2.378-52262126-130196921119411382620-62131551126
Income Before Tax 15021432268302313-261281101.97210.006487.643225.895304.609286.53377.22583.18685.029-33.778456.225134.852119.93584.028213.514-35.472416.361-61118-107214-13962-30337662091435462231-2020113632016620343214
Income Before Tax Ratio 0.0090.0010.0290.0190.0180.022-0.0180.0210.0070.0160.0340.0180.0150.0170.0220.0050.005-0.0020.0270.0080.0070.0060.014-0.0020.024-0.0040.008-0.0080.014-0.0110.005-0.0030.0230.0050.0160.0010.0230.0050.018-0.0020.0140.0110.0260.0140.0150.0040.019
Income Tax Expense 115911510887112106118-2.19390.482160.13181.603122.89798.334119.40232.42523.863-18.529128.85948.433118.52428.02563.4527.584138.33815142253102401832275141562787285813173813093
Net Income 138-38318162218202-366165103.752120.529327.513144.291181.713188.196257.82250.76161.165-15.248327.36686.4181.4156.005150.064-63.057278.023-76104-85160-14938-3015444134019835144-18193781899312213121
Net Income Ratio 0.009-0.0020.0210.0120.0130.014-0.0260.0120.0070.0090.0230.0110.0090.0110.0150.0030.004-0.0010.0190.00500.0040.01-0.0040.016-0.0050.007-0.0060.01-0.0120.003-0.0030.010.0040.0100.0130.0030.011-0.0020.0130.0060.0160.0080.0090.0010.011
EPS 54.52-14.89124.5663.4685.3979.13-143.3764.6340.6447.21128.2956.5271.1873.72100.9919.8823.96-5.97128.2333.850.5521.9458.78-24.7108.9-29.7741.15-33.9363.86-59.4715.17-11.9761.4717.5652.62077.5913.7156.43-7.0575.6230.5674.0636.4447.85.0947.41
EPS Diluted 54.52-14.89124.5663.4685.3979.13-143.3764.6340.6447.21128.0956.5271.1873.72100.9919.8823.96-5.97128.2333.850.5521.9458.78-24.7108.9-29.7741.15-33.9363.86-59.4715.17-11.9761.4717.5652.62077.5913.7156.43-7.0575.6230.5674.0636.4447.85.0947.41
EBITDA 19327143221427131235127597.898207.312480.402222.226303.62264.993377.87784.279121.727-59.815458.726127.322332.56784.827214.098-10.906436.69332.5144.5-86.5229.52380.5-436098.7522929.75347.7590.75257-4.25222.75239350.519223979.75227
EBITDA Ratio 0.0120.0160.0290.0150.0160.0220.0250.020.0070.0160.0330.0170.0150.0150.0220.0050.007-0.0040.0270.0080.0190.0060.014-0.0010.0250.0020.01-0.0060.0150.0020.006-00.0240.0080.0180.0030.0230.0080.02-00.0150.0190.0290.0170.0170.0070.02